BetaGlue Therapeutics Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.11M
- Investors
-
12
BetaGlue Therapeutics General Information
Description
Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. The company offers a precision radiotherapy platform integrating radiochemistry, medical devices, and localized radiation delivery to deliver targeted treatment for solid tumor cancers, enabling oncology clinicians and healthcare providers to treat solid tumor patients with focused therapy while reducing impact on surrounding tissue.
Contact Information
Website
www.betaglue.comCorporate Office
- Via della Moscova, 3
- 20121 Milan(Lombardy)
- Italy
Corporate Office
- Via della Moscova, 3
- 20121 Milan(Lombardy)
- Italy
BetaGlue Therapeutics Timeline
BetaGlue Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Apr-2025 | $8.11M | Completed | Clinical Trials - Phase 2 | ||
| 6. Later Stage VC | 06-Jun-2024 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 08-Nov-2023 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 19-Jul-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | Completed | Clinical Trials - General | ||||
| 2. Later Stage VC | 01-Mar-2020 | $1.42M | $6.1M | Completed | Clinical Trials - General | |
| 1. Later Stage VC (Series A) | 19-Oct-2016 | $4.68M | $4.68M | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BetaGlue Therapeutics Comparisons
Industry
Financing
Details
BetaGlue Therapeutics Competitors (2)
One of BetaGlue Therapeutics’s 2 competitors is Sirtex Medical, a Private Equity-Backed company based in Woburn, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sirtex Medical | Private Equity-Backed | Woburn, MA | ||||
| Boston Scientific | Corporation | Marlborough, MA |
BetaGlue Therapeutics Patents
BetaGlue Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025068543-A1 | Polymeric radiotherapeutic particles, suspensions and methods for producing same | Inactive | 29-Sep-2023 | ||
| WO-2024236123-A1 | Compositions, devices and kits for selective internal radiation therapy of hepatocellular carcinoma | Inactive | 17-May-2023 | ||
| AU-2021277372-A1 | Methods and apparatus for controlled delivery of a sealant | Inactive | 20-May-2020 | ||
| CA-3177450-A1 | Methods and apparatus for controlled delivery of a sealant | Pending | 20-May-2020 | ||
| EP-4153427-A1 | Methods and apparatus for controlled delivery of a sealant | Inactive | 20-May-2020 | A61B17/00491 |
BetaGlue Therapeutics Signals
BetaGlue Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tech and Biomedical Foundation | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Petrone Group | Holding Company | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Fin Posillipo | Corporation | Minority |
BetaGlue Therapeutics FAQs
-
When was BetaGlue Therapeutics founded?
BetaGlue Therapeutics was founded in 2009.
-
Where is BetaGlue Therapeutics headquartered?
BetaGlue Therapeutics is headquartered in Milan, Italy.
-
What is the size of BetaGlue Therapeutics?
BetaGlue Therapeutics has 23 total employees.
-
What industry is BetaGlue Therapeutics in?
BetaGlue Therapeutics’s primary industry is Drug Discovery.
-
Is BetaGlue Therapeutics a private or public company?
BetaGlue Therapeutics is a Private company.
-
What is the current valuation of BetaGlue Therapeutics?
The current valuation of BetaGlue Therapeutics is .
-
What is BetaGlue Therapeutics’s current revenue?
The current revenue for BetaGlue Therapeutics is .
-
How much funding has BetaGlue Therapeutics raised over time?
BetaGlue Therapeutics has raised $49M.
-
Who are BetaGlue Therapeutics’s investors?
Tech and Biomedical Foundation, , Petrone Group, European Innovation Council, and Fin Posillipo are 5 of 12 investors who have invested in BetaGlue Therapeutics.
-
Who are BetaGlue Therapeutics’s competitors?
Sirtex Medical and Boston Scientific are competitors of BetaGlue Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process